News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
203,661 Results
Type
Article (4685)
Company Profile (94)
Press Release (198882)
Section
Business (62893)
Career Advice (97)
Deals (11916)
Drug Delivery (3)
Drug Development (34417)
Employer Resources (12)
FDA (3868)
Job Trends (3784)
News (113014)
Policy (8373)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (219)
Allergies (25)
Alliances (16730)
ALS (25)
Alzheimer's disease (378)
Antibody-drug conjugate (ADC) (27)
Approvals (3908)
Artificial intelligence (35)
Autoimmune disease (4)
Automation (1)
Bankruptcy (56)
Best Places to Work (3232)
BIOSECURE Act (1)
Biosimilars (28)
Biotechnology (66)
Bladder cancer (19)
Brain cancer (12)
Breast cancer (57)
Cancer (580)
Cardiovascular disease (30)
Career advice (88)
Career pathing (2)
CAR-T (38)
Cell therapy (103)
Cervical cancer (2)
Clinical research (29407)
Collaboration (225)
Compensation (208)
Complete response letters (3)
COVID-19 (488)
CRISPR (5)
C-suite (69)
Cystic fibrosis (21)
Data (675)
Depression (10)
Diabetes (55)
Diagnostics (884)
Digital health (1)
Diversity, equity & inclusion (2)
Drug discovery (30)
Drug pricing (2)
Duchenne muscular dystrophy (16)
Earnings (26285)
Editorial (2)
Employer branding (1)
Employer resources (11)
Events (35931)
Executive appointments (232)
FDA (4187)
Featured Employer (19)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (161)
Gene editing (11)
Generative AI (1)
Gene therapy (38)
GLP-1 (150)
Government (573)
Guidances (12)
Healthcare (2609)
Huntington's disease (5)
IgA nephropathy (8)
Immunology and inflammation (19)
Indications (10)
Infectious disease (511)
Inflammatory bowel disease (46)
Influenza (10)
Intellectual property (28)
Interviews (12)
IPO (6298)
IRA (2)
Job creations (711)
Job search strategy (82)
Kidney cancer (5)
Layoffs (36)
Legal (1509)
Liver cancer (26)
Lung cancer (95)
Lymphoma (43)
Management (4)
Manufacturing (71)
MASH (29)
Medical device (1353)
Medtech (1354)
Mergers & acquisitions (5836)
Metabolic disorders (159)
Multiple sclerosis (22)
NASH (7)
Neurodegenerative disease (18)
Neuropsychiatric disorders (2)
Neuroscience (514)
NextGen: Class of 2025 (881)
Non-profit (234)
Northern California (919)
Now hiring (3)
Obesity (71)
Opinion (15)
Ovarian cancer (21)
Pain (19)
Pancreatic cancer (18)
Parkinson's disease (36)
Partnered (2)
Patents (53)
Patient recruitment (30)
Peanut (14)
People (18236)
Pharmaceutical (34)
Phase I (8574)
Phase II (13200)
Phase III (9848)
Pipeline (335)
Policy (5)
Postmarket research (673)
Preclinical (3132)
Press Release (13)
Prostate cancer (19)
Psychedelics (4)
Radiopharmaceuticals (105)
Rare diseases (85)
Real estate (1403)
Recruiting (7)
Regulatory (6790)
Reports (12)
Research institute (259)
Resumes & cover letters (6)
RSV (3)
Schizophrenia (33)
Series A (28)
Series B (16)
Service/supplier (2)
Sickle cell disease (5)
Southern California (732)
Sponsored (1)
Startups (1019)
State (1)
Supply chain (11)
United States (6850)
Vaccines (91)
Venture capitalists (3)
Webinars (4)
Weight loss (14)
Women's health (2)
Date
Today (86)
Last 7 days (348)
Last 30 days (1053)
Last 365 days (12611)
2025 (1964)
2024 (12926)
2023 (14899)
2022 (19508)
2021 (20733)
2020 (18087)
2019 (11627)
2018 (8459)
2017 (10546)
2016 (8923)
2015 (11493)
2014 (8722)
2013 (6634)
2012 (6716)
2011 (6795)
2010 (6656)
Location
Africa (134)
Alabama (15)
Arizona (24)
Arkansas (2)
Asia (26989)
Australia (3379)
California (1923)
Canada (548)
China (280)
Colorado (54)
Connecticut (71)
Delaware (63)
Europe (30683)
Florida (227)
Georgia (55)
Idaho (3)
Illinois (83)
India (8)
Indiana (51)
Japan (80)
Kansas (53)
Kentucky (7)
Louisiana (1)
Maine (6)
Maryland (214)
Massachusetts (1509)
Michigan (30)
Minnesota (89)
Missouri (11)
Nebraska (5)
Nevada (3)
New Hampshire (2)
New Jersey (732)
New Mexico (4)
New York (675)
North Carolina (302)
Northern California (919)
Ohio (51)
Oklahoma (2)
Oregon (10)
Pennsylvania (331)
Puerto Rico (1)
South America (197)
Southern California (732)
Tennessee (8)
Texas (184)
Utah (39)
Virginia (53)
Washington D.C. (9)
Washington State (97)
Wisconsin (11)
203,661 Results for "xtl biopharmaceuticals ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
XTL Biopharmaceuticals Ltd. announced that the Company received a written notification from the Nasdaq Stock Market LLC on October 18, 2023, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Rules for continued listing on the Nasdaq.
October 20, 2023
·
5 min read
Press Releases
Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044
January 2, 2025
·
2 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Press Releases
Boston Scientific announces agreement to acquire SoniVie Ltd.
March 4, 2025
·
7 min read
Press Releases
Kestra Medical Technologies, Ltd. Announces Launch of Initial Public Offering
February 27, 2025
·
2 min read
Press Releases
Kestra Medical Technologies, Ltd. Appoints Neil Bhalodkar as Vice President of Investor Relations
February 26, 2025
·
1 min read
Business
Mid-Atlantic BioTherapeutics, Inc. and SMITM Capital Markets Ltd enter into a significant financing agreement
SMITM CAPITAL MARKETS LTD, has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT), a clinical-stage ready US biopharmaceutical company.
June 19, 2024
·
4 min read
Press Releases
Basel Medical Group Ltd Prices US$8,820,000 Initial Public Offering
February 26, 2025
·
5 min read
Press Releases
NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.
February 21, 2025
·
4 min read
Press Releases
Kangpu Biopharmaceuticals Received IND Approval from NMPA for KPG-818 to Treat Relapsed/Refractory Multiple Myeloma
February 26, 2025
·
1 min read
1 of 20,367
Next